 |
 |
|
|
|
RESÚMENES MARZO 2010 |
Other Neuropsychiatric
Disorders & General Information
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o estudio
aleatorizado; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3 -
Reasons
and Determinants for Not Receiving Treatment for Common Mental Disorders
Ilse
van Beljouw, Peter Verhaak,
Marijn Prins, Pim Cuijpers, Brenda Penninx, and Jozien Bensing
Psychiatr Serv 61:250-257,
March 2010
GRATIS 3 -
Antipsychotic
treatments for the elderly: efficacy and safety of aripiprazole
Izchak
Kohen, Paula E Lester,
Sum Lam
Neuropsychiatric Disease and
Treatment. Published Date March 2010 , Volume 2010:6
3 -
Off-Label
Medication Use in Frontotemporal Dementia
Bei
Hu,
Leslie Ross, John Neuhaus, David Knopman, Joel Kramer, Bradley Boeve,
Richard
J. Caselli, Neill Graff-Radford, Mario F. Mendez, Bruce L. Miller, Adam
L.
Boxer
American
Journal of Alzheimer's Disease and Other Dementias®, Vol. 25, No.
2, 128-133
(2010)
3! -
Safety
and Tolerability of Donepezil in Mild Cognitive Impairment: Open-Label
Extension Study
Rachelle
S. Doody, Steven Ferris, Stephen Salloway, Yijun Sun, Robert Goldman,
Yikang
Xu, Jeff Gao, Anita K. Murthy
American
Journal of Alzheimer's Disease and Other Dementias®, Vol. 25, No.
2, 155-159
(2010)
3 -
Efficacy
and tolerability of duloxetine in the treatment of patients with
borderline
personality disorder: a pilot study
S.
Bellino, E. Paradiso, P. Bozzatello, F. Bogetto
Journal
of Psychopharmacology, Vol. 24, No. 3, 333-339 (2010)
3 -
Ibuprofen
modifies cognitive disease progression in an Alzheimer’s mouse
model
D. Van Dam, K. Coen, PP De
Deyn
Journal
of Psychopharmacology, Vol. 24, No. 3, 383-388 (2010)
3 - Catatonia
and Its Treatment
Patricia
I. Rosebush and Michael
F. Mazurek
Schizophrenia Bulletin 2010
36(2):239-242
3 -
Emerging
treatments for narcolepsy and its related disorders
Seiji
Nishino
Expert
Opinion on Emerging Drugs. March 2010, Vol. 15, No. 1, Pages 139-158
5< -
Controlled
clinical, polysomnographic and psychometric studies on differences
between
sleep bruxers and controls and acute effects of clonazepam as compared
with
placebo
Alexander Saletu,
Silvia Parapatics, Peter Anderer, Michael Matejka and
Bernd Saletu
3! - Antipsychotics and
risk of
cerebrovascular events in treatment of behavioural and psychological
symptoms
of dementia in Hong Kong: a hospital-based, retrospective, cohort study
Man-chak Chan,
Catherine Shiu-yin Chong, Anna
Ying-king Wu, Kai-choi Wong, Eva Lai-wah Dunn, Orlando Wai-nang Tang,
Wah-fat
Chan
International Journal of
Geriatric Psychiatry. Volume 25 Issue
4, Pages 362 - 370
3! - Safety and
tolerability of
rivastigmine capsule with memantine in patients with probable
Alzheimer's
disease: a 26-week, open-label, prospective trial (Study ENA713B US32)
Jason T. Olin, Vinod
Bhatnagar, Patricio Reyes,
Barbara Koumaras, Xiangyi Meng, Stephen Brannan
International Journal of
Geriatric Psychiatry. Volume 25 Issue
4, Pages 419 - 426
3! - Should We Expand
the Toolbox of Psychiatric Treatment Methods to
Include Repetitive Transcranial Magnetic Stimulation (rTMS)? A
Meta-Analysis of
the Efficacy of rTMS in Psychiatric Disorders
Christina
W. Slotema, Jan Dirk Blom, Hans W. Hoek, and Iris E. C. Sommer
3 - The
neuropsychiatry of multiple sclerosis: Focus on disorders of mood,
affect and
behaviour
Thomas
Paparrigopoulos,
Panagiotis Ferentinos
International Review of
Psychiatry. 2010, Vol. 22, No. 1, Pages 14-21
5 -
Sertraline for the Treatment of Depression in Alzheimer Disease:
Week-24
Outcomes
Weintraub,
Daniel; Rosenberg, Paul B; Drye, Lea T; Martin, Barbara K; Frangakis,
Constantine; Mintzer, Jacobo E; Porsteinsson, Anton P; Schneider, Lon
S;
Rabins, Peter V; Munro, Cynthia A; Meinert, Curtis L; Lyketsos,
Constantine G;
For the DIADS-2 Research Group
American Journal of Geriatric
Psychiatry: April 2010 - Volume 18 - Issue 4 - pp 332-340
3 -
Methylphenidate
for Apathy and Functional Status in Dementia of the Alzheimer Type
Padala,
Prasad R; Burke, William J; Shostrom, Valerie K; Bhatia, Subhash C;
Wengel,
Steven P; Potter, Jane F; Petty, Frederick
American Journal of Geriatric
Psychiatry: April 2010 - Volume 18 - Issue 4 - pp 371-374
GRATIS (previo
registro) 3!
-
Biomarcadores en el líquido cefalorraquídeo de pacientes
con deterioro
cognitivo leve: metaanálisis de su capacidad predictiva para el
diagnóstico de
la enfermedad de Alzheimer
J.A.
Monge-Argilés, J. Sánchez-Payá, C.
Muñoz-Ruiz,
A. Pampliega-Pérez, J. Montoya-Gutiérrez, C. Leiva-Santana
GRATIS 3! - A
Novel Analytical Framework for Dissecting the Genetic Architecture of
Behavioral Symptoms in Neuropsychiatric Disorders
Deo AJ,
Costa R, DeLisi LE,
DeSalle R, Haghighi F
3! - For
What Diagnoses Are Psychotropic Medications Being Prescribed?: A
Nationally
Representative Survey of Physicians
Mark,
Tami L
CNS Drugs: 1 April 2010 - Volume 24 - Issue
4 - pp
319-326
3! - Pre-existing
cardiovascular conditions and pharmacological treatment of adult ADHD
Tobias Gerhard,
Almut G. Winterstein, Mark Olfson, Cecilia
Huang, Arwa Saidi, Stephen Crystal
Pharmacoepidemiology and Drug Safety. Early
View. Published
Online: 16 Mar 2010
3 - Therapy for male patients
with sexual dysfunction
Casella R
Ther Umsch. 2010 Mar;67(3):123-8
3! -
Early-Versus
Late-Onset Alzheimer's Disease: More than Age Alone
Esther L.G.E.
Koedam, Vivian Lauffer, Annelies E. van
der Vlies, Wiesje M. van der Flier, Philip Scheltens, Yolande A.L.
Pijnenburg
Journal of Alzheimer's Disease. Volume 19,
Number 4 /
2010:1401-1408
5 - Randomized
controlled trial of atorvastatin in mild
to moderate Alzheimer disease
H.
H.
Feldman, R. S. Doody, M. Kivipelto, D. L. Sparks, D. D. Waters, R. W.
Jones, E.
Schwam, R. Schindler, J. Hey-Hadavi, D. A. DeMicco, A. Breazna, On
behalf of
the LEADe Investigators
3 - Stopping Randomized
Trials Early for Benefit and Estimation of
Treatment Effects. Systematic
Review and Meta-regression Analysis
Dirk Bassler,
Matthias
Briel, Victor M. Montori, Melanie Lane, Paul Glasziou, Qi Zhou, Diane
Heels-Ansdell, Stephen D. Walter, Gordon H. Guyatt, and the STOPIT-2
Study
Group
3 -
Laboratory
Parameters and Appetite Regulators in Patients with Anorexia Nervosa
Himmerich,
Hubertus; Schönknecht, Peter; Heitmann, Sabine; Sheldrick, Abigail
J
Journal of Psychiatric Practice: March 2010
- Volume
16 - Issue 2 - pp 82-92
GRATIS 3! - The quality of
reports of
randomised trials in 2000 and 2006: comparative study of articles
indexed in
PubMed
Sally Hopewell, Susan
Dutton, Ly-Mee Yu,
An-Wen Chan, Douglas G Altman
GRATIS 3! - CONSORT 2010
Statement:
updated guidelines for reporting parallel group randomised trials
Kenneth F Schulz,
Douglas G Altman, David Moher,
for the CONSORT Group
3 - Effects of
antidepressant
treatment on N-acetyl aspartate
and choline levels in the hippocampus and thalami of post-stroke
depression
patients: A study using 1H magnetic resonance spectroscopy
Yanyan
Huang, Wenjie Chen, Yuxin Li, Xiaoyan Wu, Xiaomei
Shi and
Daoying Geng
Psychiatry Research:
Neuroimaging. Volume 182, Issue 1, 30 April 2010, Pages 48-52
3 - Armodafinil
in the
treatment of excessive sleepiness
Richard
K Bogan
Expert Opinion on Pharmacotherapy. April
2010,
Vol. 11, No. 6, Pages 993-1002
3 -
Advances
in the Pharmacological Management of Huntington's Disease
Frank,
Samuel; Jankovic, Joseph
Drugs: 26 March 2010 - Volume 70 - Issue 5
- pp
561-571
5< - Efficacy of
Venlafaxine for Symptomatic Relief in
Young Adult Patients With Functional Chest Pain: A Randomized,
Double-Blind,
Placebo-Controlled, Crossover Trial
Hyuk Lee,
Jeong Hwan Kim, Byung-Hoon Min, Jun Haeng Lee, Hee
Jung Son,
Jae J Kim, Jong Chul Rhee, Young Ju Suh, Seonwoo Kim and Poong-Lyul Rhee
Am J Gastroenterol advance online publication
23 March 2010
3 - Non-Steroidal Anti-Inflammatory Drugs and Alzheimer's
Disease: The Epidemiological Evidence
Szekely,
C.A; Zandi, P.P
CNS
& Neurological Disorders - Drug Targets. Volume 9, Number 2,
April
2010 , pp. 132-139(8)
| Regresar a RESÚMENES MARZO 2010 |
©
1999-2010 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
| Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA |